Interactions between PCSK9 and NLRP3 inflammasome signaling in atherosclerosis

Atherosclerosis is an early pathological basis of numerous cardiovascular events that result in death or disability. Recent studies have described PCSK9 as a novel target for the treatment of atherosclerosis; PCSK9 is capable of degrading LDLR on the surface of hepatocytes through the regulation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanan, Fang, Dan, Yang, Qinzhi, You, Jingcan, Wang, Liqun, Wu, Jianbo, Zeng, Min, Luo, Mao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992811/
https://www.ncbi.nlm.nih.gov/pubmed/36911736
http://dx.doi.org/10.3389/fimmu.2023.1126823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992811/
https://www.ncbi.nlm.nih.gov/pubmed/36911736
http://dx.doi.org/10.3389/fimmu.2023.1126823

Ejemplares similares